Author: Escosaâ€GarcÃa, Luis; Aguileraâ€Alonso, David; Calvo, Cristina; Mellado, MarÃa José; Baqueroâ€Artigao, Fernando
Title: Ten key points about COVIDâ€19 in children: the shadows on the wall Cord-id: lfwqzf8m Document date: 2020_8_13
ID: lfwqzf8m
Snippet: The pandemic of the new coronavirus disease (COVIDâ€19) caused by the severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2), initially described in China, is challenging the healthcare systems of all countries. Every emerging disease raises many questions with a scarcity of answers since all its characteristics are still being discovered. In the case of SARSâ€CoVâ€2, most of the literature comes from adult patients. Children seem to be less affected. Pediatric patients diagnosed wi
Document: The pandemic of the new coronavirus disease (COVIDâ€19) caused by the severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2), initially described in China, is challenging the healthcare systems of all countries. Every emerging disease raises many questions with a scarcity of answers since all its characteristics are still being discovered. In the case of SARSâ€CoVâ€2, most of the literature comes from adult patients. Children seem to be less affected. Pediatric patients diagnosed with COVIDâ€19 disease usually suffer a mild illness, with low risk of complications or mortality. Defining the role of children in the transmission of SARSâ€CoVâ€2 is critical as some national infection control decisions involving children, such as school closures or social distancing, will probably impact the dynamics of the virus. To aid in the knowledge on COVIDâ€19 in children, this work presents an expert review of the literature published from January 1 to April 20, 2020, including peerâ€reviewed and preâ€print nonâ€peerâ€reviewed studies, along with some relevant articles afterwards, summarizing ten key points that characterize the disease in children. This article is protected by copyright. All rights reserved.
Search related documents:
Co phrase search for related documents- abnormal liver and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- abnormal liver and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- abnormal liver and liver procalcitonin: 1, 2, 3
- abnormal liver and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- abnormal liver and low prevalence: 1
- abnormal liver and lung disease: 1
- abnormal liver and lung infection: 1
- abnormal liver and lymphocyte count: 1, 2, 3, 4, 5, 6, 7
- abnormal liver function and absence presence: 1
- abnormal liver function and acute disease: 1, 2, 3, 4, 5, 6, 7, 8
- abnormal liver function and liver enzyme: 1, 2, 3, 4, 5, 6
- abnormal liver function and liver procalcitonin: 1, 2, 3
- abnormal liver function and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9
- abnormal liver function and lymphocyte count: 1, 2, 3, 4, 5, 6
- absence presence and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- absence presence and liver enzyme: 1, 2, 3
- absence presence and lopinavir ritonavir: 1, 2
- absence presence and low prevalence: 1, 2, 3, 4
- absence presence and low seroprevalence: 1
Co phrase search for related documents, hyperlinks ordered by date